Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia
Recruiting · NCT05881265 · Registry updated 2025-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia | acute promyelocytic leukemia | Recruiting | Phase 2 | 2025-02-18 | NCT05881265 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Clinical Research Center | 2 |
| Shanghai Jiao Tong University School of Medicine | 117 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jiong HU | Shanghai | China | 1 |
| Nanfang Hospital | Guangzhou | China | 4 |
| The Affiliated Huai An No 1 Perople's Hospital of NanJing University | Huai'an | China | 1 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 77 |
| Zhaxin Hospital, Go Broad Health Care | Shanghai | China | 2 |